Please login to the form below

Not currently logged in
Email:
Password:

Almirall

This page shows the latest Almirall news and features for those working in and with pharma, biotech and healthcare.

Almirall looks to crowdsource new skin health treatments

Almirall looks to crowdsource new skin health treatments

Almirall looks to crowdsource new skin health treatments. Launches open innovation platform AlmirallShare. ... Spanish pharma company Almirall has set up an online open innovation platform through which it hopes to find skin health solutions.

Latest news

More from news
Approximately 11 fully matching, plus 67 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    12. Symatese. Almirall. Development collaboration. Customised products in aesthetics. 8. AgaImmune.

  • Deal Watch December 2016 Deal Watch December 2016

    510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... $21m plus $80m equity. Biosimilars. Nuevolution. Almirall. $453m. $11.8m. Inhibitors to transcription

  • Deal Watch October 2016 Deal Watch October 2016

    $575m. $198m. 2.9. Respiratory 2014. Almirall. Products pipeline. $2, 100 milestones.

  • Deal Watch July 2016 Deal Watch July 2016

    Celyad. $311m. $12.5m. Almirall. Patagonia. $28m. $3.5m. Petra Pharma. Sprint BioScience. ... Almirall's initial expenditure has been a more modest $3.5m for this earlier stage product.

  • Stronger together Stronger together

    Also speaking at the eyeforpharma conference was Almirall's CEO Eduardo Sanchiz, who noted that, while patient-centricity is often talked about in the industry, “ we have difficulties putting it in

More from intelligence
Approximately 2 fully matching, plus 10 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Solaris Health

    Abbvie. Aimmune. Almirall. Ascensia. BD. Bio-Medical Research. Desitin. Ferring. Flexyfoot. Gedeon Richter.

  • HAVAS LYNX

    AbbVie. Alexion. Almirall. Astellas. AstraZeneca. Bayer. Eisai. Genzyme. Janssen. Kowa. Lilly.

  • nitrogen

    CHISWICK OFFICE:. MARLOW OFFICE:. Abbott Nutrition. Almirall. Astellas. Astellas. Covidien. AstraZeneca.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...
So how do you really engage with patients?
The most valuable insights from patient engagement are the most unexpected ones. Simple things, which may seem unimportant to you, may be the key to making patients’ lives easier and...
data
Avoiding data pitfalls in clinical research
Genomics sequencing and sensors will present new challenges...

Infographics